- Home
- CMPX vs SCPH Comparison
CMPX vs SCPH Comparison
Compare CMPX & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SCPH
- Stock Information
- Founded
- CMPX 2014
- SCPH 2013
- Country
- CMPX United States
- SCPH United States
- Employees
- CMPX N/A
- SCPH N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- CMPX Health Care
- SCPH Health Care
- Exchange
- CMPX Nasdaq
- SCPH Nasdaq
- Market Cap
- CMPX 291.8M
- SCPH 173.6M
- IPO Year
- CMPX N/A
- SCPH 2017
- Fundamental
- Price
- CMPX $2.65
- SCPH $4.51
- Analyst Decision
- CMPX Strong Buy
- SCPH Strong Buy
- Analyst Count
- CMPX 9
- SCPH 3
- Target Price
- CMPX $12.67
- SCPH $14.00
- AVG Volume (30 Days)
- CMPX 797.6K
- SCPH 261.6K
- Earning Date
- CMPX 08-11-2025
- SCPH 08-13-2025
- Dividend Yield
- CMPX N/A
- SCPH N/A
- EPS Growth
- CMPX N/A
- SCPH N/A
- EPS
- CMPX N/A
- SCPH N/A
- Revenue
- CMPX $850,000.00
- SCPH $41,982,000.00
- Revenue This Year
- CMPX N/A
- SCPH $108.95
- Revenue Next Year
- CMPX N/A
- SCPH $73.83
- P/E Ratio
- CMPX N/A
- SCPH N/A
- Revenue Growth
- CMPX N/A
- SCPH 138.10
- 52 Week Low
- CMPX $0.87
- SCPH $1.94
- 52 Week High
- CMPX $4.08
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- CMPX 64.52
- SCPH 60.01
- Support Level
- CMPX $2.62
- SCPH $3.83
- Resistance Level
- CMPX $2.87
- SCPH $4.18
- Average True Range (ATR)
- CMPX 0.16
- SCPH 0.17
- MACD
- CMPX 0.00
- SCPH -0.02
- Stochastic Oscillator
- CMPX 81.03
- SCPH 76.60
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.